
GLPH
Healthcare · Biotechnology · $826,160 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 31, 2019 | Time not confirmed | — | -0.02 | — |
| Feb 28, 2019 | Time not confirmed | — | -0.01 | — |
| Nov 30, 2018 | Time not confirmed | — | -0.00 | — |
| Aug 31, 2018 | Time not confirmed | — | -0.01 | — |
| May 31, 2018 | Time not confirmed | — | -0.01 | — |
| Feb 28, 2018 | Time not confirmed | — | -0.01 | — |
Gala Pharmaceutical, Inc. focuses on the research, development, and commercialization of products derived from the hemp and cannabis plant. The company also provides genetic fingerprinting and sequencing services for various crop species. In addition, it offers consulting services on testing and manufacturing lab designs and SOPs, as well as services to customers for building turnkey labs, drug formulations, and…